Core Viewpoint - Caring Brands Inc. has announced the issuance of two new U.S. patents that enhance its intellectual property portfolio for the Hair Enzyme Booster product, aimed at improving hair loss treatments [1][2][3] Patent Issuance - The patents, granted in January 2026, focus on technologies that increase sulfotransferase enzyme activity, which is crucial for the effectiveness of topical hair loss treatments [2] - These patents provide exclusive protection for mechanisms central to the Hair Enzyme Booster, which is generating revenue through direct sales in the U.S. and international licensing [2] Company Strategy - The CEO of Caring Brands highlighted that the patents represent a significant milestone, validating the scientific basis of the Hair Enzyme Booster technology and enhancing the company's competitive position [3] - The company is committed to developing, protecting, and commercializing proprietary technologies with substantial clinical and commercial potential, with plans for further updates on product development and distribution [3] Product Portfolio - Caring Brands has a growing portfolio of patented and clinically validated products for skin and hair growth, with plans to launch five additional products over the next two years [4] - Current revenue is generated from the Hair Enzyme Booster and Photocil, with additional product opportunities including CB-101 for eczema and NoStingz sunscreen [4]

Core Insights - Caring Brands Inc. has entered into an exclusive worldwide license agreement with Itonis Inc. to manufacture, market, and distribute Emesyl, an OTC nausea relief product, which provides Caring Brands with full commercialization rights [1][2] Company Overview - Caring Brands Inc. has a growing portfolio of unique, patented, and clinically validated products for skin and hair growth, with plans to launch a total of 5 products over the next 2 years [5] - The company has a successful track record in strategic acquisitions, rapid product development, intellectual property development, and product licensing [5] Market Context - The global market for nausea treatment and related therapies is projected to exceed USD 6.23 billion in 2025, highlighting the commercial potential for the Emesyl license [3] Agreement Details - Under the agreement, Caring Brands will handle product manufacturing, marketing, sales strategy, and global distribution, while Itonis will provide necessary technical and historical sales information [2] - The agreement includes a royalty structure based on future net sales and the potential for Caring Brands to earn equity in Itonis tied to revenue milestones [4]

FORT PIERCE, Fla., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Caring Brands, Inc. (“Caring Brands” or the “Company”), a wellness consumer products company offering several over-the-counter (OTC) and cosmetic consumer products, today announced the closing of its underwritten U.S. public offering of 1,000,000 shares of common stock at a public offering price of $4.00 per share for aggregate gross proceeds of approximately US $4,000,000, prior to deducting underwriting discounts and offering expenses (the “Offering”). ...

Financial Performance - Net sales for the three months ended September 30, 2025, were $740,000, while the company had no revenue in the comparable periods of 2024 [78]. - The net loss for the three months ended September 30, 2025, was $1,018,768, compared to a net loss of $428,906 in the Successor 2024 Period [78]. - Net cash used in operating activities for the nine months ended September 30, 2025, was $631,875, including a net loss of $2,218,121 [88]. Expenses - SG&A expenses increased to $999,923 for the three months ended September 30, 2025, compared to $156,091 in the Predecessor QTD Period, primarily due to shares issued for consulting and investor relations services [79]. - SG&A expenses for the nine months ended September 30, 2025, totaled $2,200,504, significantly higher than $654,573 in the Predecessor YTD Period [83]. - Interest expense for the nine months ended September 30, 2025, was $19,720, compared to $67 in the Predecessor YTD Period, primarily due to a new term loan [84]. Liquidity and Funding - As of September 30, 2025, the company had $16,123 in cash and cash equivalents and a borrowing capacity of $80,000 under a Term Loan agreement [85]. - The company expects to raise approximately $4.0 million through a public offering to support liquidity and product development over the next twelve months [86]. Product Development - The company is still in the process of developing and commercializing its products, resulting in inconsequential net sales and cost of sales for both the three and nine months ended September 30, 2025 [78][82]. - The company is taking steps to establish formal processes and controls for disclosure and internal controls as it matures as a public company [102].

Core Points - Caring Brands, Inc. has announced a public offering of 1,000,000 common shares at a price of $4.00 per share, aiming for gross proceeds of approximately $4,000,000 before deductions [1][2] - The company has granted underwriters a 45-day option to purchase an additional 150,000 shares at the public offering price [2] - The offering is expected to close on November 14, 2025, subject to customary closing conditions [2] - Caring Brands has received approval to list its shares on the Nasdaq Capital Markets under the symbol "CABR," with trading expected to begin on or around November 13, 2025 [3] - The net proceeds from the offering will be used for general and working capital purposes, including marketing and sales of proprietary products and repayment of certain debt [4] - A registration statement related to the offering was filed with the SEC and was declared effective on October 30, 2025 [5] Company Overview - Caring Brands is a wellness consumer products company that offers a range of over-the-counter (OTC) and cosmetic products [7] - The product pipeline includes treatments for hair loss, eczema, psoriasis, vitiligo solutions, and a jellyfish sting protective suncare line [7] - The company ensures that all products have established mechanisms of action, determined efficacy through clinical trials, and are protected by patents [7]

As filed with the Securities and Exchange Commission on October 10, 2025. Registration No. 333-289767 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 3 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CARING BRANDS, INC. (Primary Standard Industrial Classification Code Number) Nevada 2844 99-4103908 (I.R.S. Employer Identification Number) 130 S Indian River Drive, Suite 202 pbm# 1232, Fort Pierce, FL 34950 Tel: (561) 896-7616 (Address, including zip c ...

As filed with the Securities and Exchange Commission on September 19, 2025. Registration No. 333-289767 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CARING BRANDS, INC. (Exact Name of Registrant as Specified in its Charter) (State or Other Jurisdiction of Incorporation or Organization) (Primary Standard Industrial Classification Code Number) Nevada 2844 99-4103908 (I.R.S. Employer Identification Nu ...

As filed with the Securities and Exchange Commission on September 08, 2025. Registration No. 333-289767 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CARING BRANDS, INC. (Exact Name of Registrant as Specified in its Charter) (State or Other Jurisdiction of Incorporation or Organization) (Primary Standard Industrial Classification Code Number) Nevada 2844 99-4103908 (I.R.S. Employer Identification Nu ...

As filed with the Securities and Exchange Commission on August 21, 2025. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CARING BRANDS, INC. (Exact Name of Registrant as Specified in its Charter) (State or Other Jurisdiction of Incorporation or Organization) Nevada 2844 99-4103908 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) 130 S Indian River Dri ...

As filed with the Securities and Exchange Commission on April 7, 2025. Registration No. 333-285964 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 To FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CARING BRANDS, INC. (Exact Name of Registrant as Specified in its Charter) (State or Other Jurisdiction of Incorporation or Organization) (Primary Standard Industrial Classification Code Number) Nevada 2844 99-4103908 (I.R.S. Employer Identification Number) ...